A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

Discover a study that explores how a personalised mHealth exercise program can effectively improve ADHD symptoms in children.

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

While ADHD medications continue to reduce the risk for self-harm, injury, and car crashes, recent expanded prescribing ...

You likely are accustomed to encountering a range of menus in daily life, but there is one that may be new to you: a dopamine ...

Is creativity really a strength of autism? A new study says not necessarily. When controlling for ADHD and cognitive ability, ...

New Zealanders with attention-deficit hyperactivity disorder (ADHD) will now have easier access to diagnosis and medication ...